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Objectives: Diabetes mellitus is a major public health problem worldwide. Most diabetic patients will develop
functional disabilities due to multiple factors, including musculoskeletal (MSK) manifestations. The purpose
of this study was to determine the frequency of MSK in diabetic patients and to examine the possible
predictors for its development.
Methods: We performed a cross-sectional study from June 1, 2010, to June 30, 2011, to evaluate MSK
manifestations in adult diabetic patients at an outpatient clinic of King Abdulaziz University Hospital,
Jeddah, Saudi Arabia. Baseline variables were examined to determine predictors for the development of MSK
complications. Analyses were carried out using the Statistical Package for Social sciences.
Results: We included 252 diabetic patients; 45 (17.9%) had MSK manifestations. Of these 45 patients,
41 (91.1%) had type 2 diabetes. The most common manifestations were carpal tunnel syndrome (n17,
6.7%), shoulder adhesive capsulitis (n17, 6.7%), and diabetic amyotrophy (n12, 4.8%). A significant
association was found between the development of MSK manifestations and manual labor, overweight,
and vascular complications. On logistic regression analysis, the presence of vascular complications in general
(B-coefficient1.27, odds ratio3.57, PB0.05, 95% confidence interval1.319.78), and retinopathy in
particular (B-coefficient1.17, odds ratio3.21, PB0.05, 95% confidence interval1.477.02) can predict
the development of MSK manifestations in about 82% of the cases.
Conclusion: Musculoskeletal manifestations are under recognized in adult diabetic patients, occurring in 18%
of the cases. Physicians should consider examining the periarticular region of the joints in the hands and
shoulders whenever a diabetic patient presents with MSK symptoms.
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M
usculoskeletal (MSK) complications of dia-
betes mellitus (DM) are the most common
endocrine arthropathies. These have been
generally under-recognized and poorly treated comp-
ared with other complications, such as neuropathy,
retinopathy, and nephropathy. These manifestations,
which are some of the causes of chronic disability, involve
not only the joints, but also the bones and the soft tissues.
In 2004, the National Health Interview Survey deter-
mined that 58% of diabetic patients would have func-
tional disability (1). The percentage of diabetic patients
with functional disability will increase as the number
of diabetic patients increases, and hence constitute a
major public health problem. Recent data show that the
prevalence of MSK manifestations in the hands and
shoulders in patients with type 1 or type 2 diabetes is 30%
(2). These manifestations are closely linked to age (3),
prolonged disease duration (4, 5), and vascular complica-
tions in the form of retinopathy (6).
In Arab countries, there is a paucity of reports that
describe MSK disabilities in diabetic patients. No pre-
vious studies had been conducted to assess the prevalence
of MSK manifestations in diabetic patients or to evaluate
the predisposing factors. Thus, the aim of this study
was to evaluate the frequency of MSK manifestations in
adult diabetic patients visiting a tertiary center in Jeddah,
Saudi Arabia, and to identify the clinical and biochemical
risk factors for the development of these complications.
Methods
We performed a cross-sectional study to evaluate MSK
complications in adult diabetic patients at the Endocri-
nology Clinic of King Abdulaziz University Hospital,
Jeddah, Saudi Arabia, between June 2010 and June 2011.
King Abdulaziz University Hospital is a tertiary center
known to provide health care to a multinational popula-
tion of mixed socio-economic status. Consent was
obtained from the patients prior to their inclusion in
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the study. The study was approved by the Biomedical
Ethical Research Committee of the Faculty of Medicine
of King Abdulaziz University.
A rheumatologist examined all adult patients with type
1 and 2 diabetes for MSK manifestations of diabetes.
Patients were included provided they had a history of
DM for at least 2 years, diagnosed according to the
World Health Organization (WHO) as a fasting plasma
glucose level of]126 mg/dL (7.0 mmol/l) (7). Patients
with rheumatoid arthritis, osteoarthritis and osteoporosis
were excluded. Osteoarthritis was considered if the
patients had the classic changes of osteoarthritis in their
hands, including Heberden’s and Bouchard’s nodes.
For all patients included in the study, we recorded
the following information: demographic features, includ-
ing age, gender, nationality, and occupation, especially
manual labor, smoking habits, and the body mass index
(BMI), which was calculated as weight in kilograms
divided by height in meters squared. We considered
overweight subjects with a BMI between 25 and 29.9
and obesity with BMI30 kg/m2 as per WHO 2000
classification for BMI (8). We obtained the following
clinical information: duration of diabetes (in years); type
of diabetes (type 1 or 2); disease control; complications
due to diabetes; retinopathy (confirmed by an ophthal-
mologist or patient undergoing laser treatment); neuro-
pathy (defined as mononeuropathy, peripheral, or
autonomic neuropathy); nephropathy (defined as micro-
albuminuria, proteinuria, or renal failure); coronary
artery disease (CAD); and cerebrovascular accident
(CVA) (9). We also recorded the hemoglobin A1C
(HbA1c) levels of the patients, measured by immunoas-
say, using the Cobas Integra 800 automated analyzer
(Roche Diagnostics, Manheim, Germany) (10). We cal-
culated the mean HbA1c level from results obtained at
the most recent visit and those obtained at the last three,
over the previous year, to provide an integrated index of
glycemic control during follow up. Poor glycemic control
was considered when HbA1c levels were 8.0%.
MSK manifestations in patients with diabetes were
divided into three categories: (1) disorders that represent
intrinsic complications of diabetes, such as diabetic chei-
roarthropathy and diabetic muscle infarction; (2) disor-
ders with an increased incidence among diabetic patients,
such as Dupuytren’s disease, shoulder capsulitis, neuro-
pathic arthropathy, flexor tenosynovitis, de Quervain’s
tenosynovitis, reflex sympathetic dystrophy (RSD), dia-
betic amyotrophy, diffuse idiopathic skeletal hyperostosis,
diabetic osteolysis, septic arthritis, osteomyelitis; and (3)
disorders that have been possibly linked to diabetes, such
as carpal tunnel syndrome (CTS) and crystal arthropathy
(1113).
A systematic method was used to evaluate the patients.
First, the hands were examined, followed by the
shoulders, then spine, and finally the lower limbs. The
following definitions were used to identify all of the
manifestations:
1) Diabetic cheiroarthropathy or limited joint mobility
was evaluated by the patient ‘prayer sign’ in which
the patient was asked to approximate the palmar
surfaces of their interphalengeal joints, with the
fingers fanned and the wrist maximally extended. If
they were unable to do so, the test was considered
positive (13).
2) Diabetic sclerodactyly was defined as thickening
of the skin on the dorsal aspect of the hand
in association with limited joint mobility in the
absence of Raynaud phenomenon, calcinosis, and
telangiectasia.
3) CTS was defined as weakness or pain of the hand,
evidence of thenar atrophy, or nocturnal paresthesia
of the thumb, index, and long fingers, with or
without a positive Tinel’s or Phalen’s sign. CTS
was excluded if other causes, such as thyroid disease,
acromegaly, or C5/C6 radiculopathy were suspected.
We also considered a history of surgery as evidence
of the disease.
4) Flexor tenosynovitis or stenosing tenosynovitis or
trigger finger was diagnosed by palpating a nodule
or thickened flexor tendon with locking phenom-
enon during finger flexion or extension.
5) The diagnosis of Dupuytren’s contracture was
based on one of the following features: a palmar
or digital nodule; tethering of palmar or digital skin;
a pretendinous band and a digital flexion contrac-
ture, palpable thickening of the palmar fascia, with a
flexor deformity of the second, third, fourth, or fifth
fingers.
6) RSD was defined as unilateral, localized, or diffused
pain associated with swelling or trophic changes and
vasomotor disturbance with impaired mobility of
the affected limb.
7) Diabetic osteolysis was characterized by osteoporo-
sis of the proximal phalanges in the hands and feet,
documented by X-ray radiographs.
8) Patients with unilateral shoulder pain for at least
1 month, an inability to lie on the affected shoulder,
and restricted active and passive shoulder joint
movement of less than 50% in at least three planes
were diagnosed as frozen shoulder or adhesive
capsulitis.
9) Diffuse idiopathic skeletal hyperostosis syndrome
was diagnosed based on the classification criteria
set by Resnick and Niwayama, which requires
radiographically recognized bridges connecting at
least four contiguous vertebrae of the thoracic spine,
with preservation of the intervertebral disk space
and absence of apophyseal joints or sacroiliac
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inflammatory changes (1214). Only those with back
pain had an X-ray of the spine.
10) Charcot joint or neuropathic arthropathy was de-
fined as painless swelling and deformity at the
weight-bearing joints and the classical finding of
articular surface destruction, dislocation, disorgani-
zation, and increased density of the involved joint
on X-ray radiographs.
11) Diabetic amyotrophy was defined as wasting of the
proximal upper or lower extremity muscles or the
paraspinal muscles, preceded by severe pain and
dyesthesia of the involved part.
12) Diabetic muscle infarction was defined as a palpable
painful mass with swelling and induration of the
surrounding tissue without systemic symptoms, in
addition to evidence of edema in the muscle on
magnetic resonance imaging. A history of surgery
for was also considered as evidence of the disease
(1214).
Statistical analysis
Data analysis was carried out using the Statistical
Package for Social Sciences (SPSS Inc., Chicago, IL,
USA), version 16. Mean9standard deviation (SD) was
calculated for quantitative data and percentage for
categorical variables. Student’s t-test was used for com-
paring the means of continuous variables. Numbers and
percentages were compared by Chi-square test and
MantelHaenszel test if needed. The predictive value of
MSK manifestations for the various co-variables was
calculated using multivariate logistic regression analysis,
with a confidence interval of 95%. Results were consid-
ered significant if the P-value was B0.05.
Results
A total of 252 diabetic patients were examined during the
study period. The mean age of the patients was 56.71914
years. Eighty patients (31.7%) were Saudis. Non-Saudis
constituted 68.3% of the study population and originated
from different ethnic backgrounds. Fifty (19.8%) patients
did manual labor. Twenty-six patients (10.3%) were
smokers.
The mean duration of diabetes was 11.2198.5 years.
Type 1 diabetes was diagnosed in 36 patients (14.3%); 215
patients (85.3%) had type 2 diabetes. Only 31 patients
(12.3%) had controlled diabetes, with mean HbA1c level
of 8.692.3 mmol/L (range, 117 mmol/L). Sixty-nine
patients (27.4%) were overweight, while 128 patients
(50.8%) were obese. Vascular complications were ob-
served in 168 patients (66.7%) in the form of retinopathy
in 38 (15.1%) patients, neuropathy in 120 patients
(47.6%), nephropathy in 53 (21.0%) patients, CAD in
75 patients (29.8%) and CVA in 21patients (8.3%).
MSK manifestations were diagnosed in 45 (17.9%)
of 252 patients. MSK disorders were more common in
patients with type 2 diabetes (n41, 91.1%) than in those
with type 1 diabetes (n4, 8.9%). Almost half (48.9%)
of the patients with MSK disorders had more than
one manifestation. The manifestations were CTS and
shoulder capsulitis in 17 cases (6.7%) each, diabetic
amyotrophy in 12 patients (4.8%), flexor tenosynovitis
in 11 patients (4.4%), diabetic cheiroarthropathy in 8
patients (3.2%), crystal arthropathy in 7 patients (2.7%)
(5 patients had gout, while 2 patients had pseudogout),
diabetic sclerodactyly in 5 patients (2.0%), and plantar
fasciitis in 3 patients (1.2%). Dupuytren’s disease, muscle
infarction, neuropathic arthropathy, diffuse idiopathic
skeletal hyperostosis, de Quervain’s tenosynovitis, and
osteomyelitis were found in one case each (0.4%). None
of the patients had digital osteolysis, RSD, or septic
arthritis (Table 1).
Table 2 shows the association between the clinical
variables of diabetes control and the MSK manifestations
of DM. There was a significant association between the
development of MSK manifestations and manual labor,
overweight, and vascular complications. By logistic reg-
ression analysis, vascular complications (B-coefficient
1.27, odds ratio [OR]3.57, PB0.05, 95% confidence
interval [CI]1.319.78) and retinopathy, in particular
(B-coefficient1.17, OR3.21, PB0.05, 95% CI
1.477.02), were predictors of MSK complications in
about 80% of the cases (Table 3).
Table 1. Prevalence of musculoskeletal disorders among
studied diabetic patientsa
MSK manifestations Number %
Overall prevalence 45 17.8
Carpal tunnel syndrome 17 6.7
Shoulder adhesive capsulitis 17 6.7
Diabetic amyotrophy 12 4.8
Flexor tenosynovitis 11 4.4
Diabetic cheiroarthropathy 8 3.2
Crystal arthropathy 7 2.7
Diabetic sclerodactyly 5 2.0
Plantar fasciitis 3 1.2
Dupuytren’s disease 1 0.4
Muscle infarction 1 0.4
Charcot joint 1 0.4
Diffuse idiopathic skeletal hyperosteosis 1 0.4
De Quervain’s tenosynovitis 1 0.4
Osteomyelitis 1 0.4
Diabetic osteolysis 0 0.0
Reflex sympathetic dystrophy 0 0.0
Septic arthritis 0 0.0
MSK, musculoskeletal manifestation.
aSeveral features may co-exist.
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There was a significant association between certain
manifestations and predictors: CTS and retino-
pathy, neuropathy and CAD, shoulder capsulitis and
retinopathy and CAD, flexor tenosynovitis with retino-
pathy and neuropathy, diabetic cheiroarthropathy and
diabetic sclerodactyly with retinopathy and CAD. Also,
Table 2. Characteristics of patients with and without musculoskeletal manifestations and the association between 45 patients
with musculoskeletal manifestations and clinical variablesa
Predictor With MSK, n45 (%) Without MSK, n207 x2 P OR 95% CI
Age in years (mean9SD) 59.6399.7 56.10914.7 0.13b
Gender
Female (n147) 31 (21.1) 116 (78.9) 2.33 0.127a 1.095 (0.981.22)
Male (n105) 14 (13.3) 91 (86.7) RC
Nationality
Saudi (n80) 17 (21.3) 63 (78.8) 0.92 0.338a 1.31 (0.762.24)
Non-Saudi (n172) 28 (16) 144 (84) RC
Manual labor
Yes (n50) 4 (8) 46 (92) 4.1 0.042a,b 0.39 (0.151.05)
No (n202) 41 (20.3) 161 (79.7) 1.2 (1.041.3)
Smoking (n26) 3 (11.5) 23 (88.5) 0.8 0.37b 0.62 (0.211.86)
Duration of diabetes (mean9SD) 12.0796.84 11.01911.02 0.001a,c
Disease not controlled (n220) 41 (13) 27 (87) 0.61 0.44b 1.07 (0.921.24)
Type of diabetes
Type 1 (n37) 5 (14) 32 (86) 1.303 0.245b 0.55 (0.181.59)
Type 2 (n215) 41 (19) 174 (81) 1.55 0.3 1.2 (0.961.25)
Weight
Underweight (n11) 2 (18) 9 (82) 0.03 0.56b 1.15 (0.235.64)
Normal (n44) 13 (30) 31 (70) RC
Overweight (n69) 5 (10) 64 (90) 7.3 0.007a,b 0.332 (0.140.81)
Obesity (n128) 25 (19) 103 (81) 0.49 0.25 1.26 (0.662.41)
Hemoglobin A1c level 8.591.94 8.692.3 0.8
Complications
Yes (n168) 40 (24) 128 (76) 12.17 0.001a,b 4 (1.649.76)




Yes (n38) 16 (42) 22 (58) 17.94 0.001a,b 3.1 (1.885.14)
No (n214) 29 (14) 185 (86) RC
Nephropathy
Yes (n53) 14 (26) 39 (74) 3.3 0.07b 1.7 (0.972.93)
No (n199) 32 (16) 167 (84) RC
Neuropathy
Yes (n120) 30 (25) 90 (75) 7.97 0.005a,b 2.2 (1.253.88)
No (n132) 15 (11) 117 (89) RC
CAD
Yes (n75) 21 (28) 54 (72) 7.5 0.006a,b 2.1 (1.233.47)
No (n177) 24 (14) 153 (86) RC
CVA
Yes (n21) 6 (29) 19 (71) 1.79 0.181b 1.69 (0.813.53)
No (n231) 39 (17) 192 (83) RC
CAD, coronary artery disease; CI, confident interval; CVA, cerebrovascular accident; MSK, musculoskeletal; OR, odds ratio, RC,
Reference category.
Data were presented as frequencies (percentages) unless otherwise stated.
aSignificant association, PB0.05.
P was calculated by bChi-square test, cMannWhitney U test.
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an association was observed between one manifestation
and another: Shoulder adhesive capsulitis with CTS (PB
0.05), flexor tenosynovitis (PB0.007), and limited joint
mobility (PB0.001). Table 4 summarizes the MSK
manifestations in relation to weight and vascular com-
plications of DM by Chi-square testing.
Discussion
Our study showed three important findings. First,
the frequency of MSK manifestations in DM was
17.9%. Second, the most common MSK manifestations
were CTS and adhesive capsulitis (6.7% in each case).
Third, there was a significant association between
vascular complications and the development of MSK
manifestations.
It is estimated that more than 50% of diabetic patients
will suffer from chronic disability (1). Some factors that
contribute to chronic disability in diabetic patients
include vascular complications, in addition to predispos-
ing conditions, such as obesity and low physical activity.
It was reported that patients with type 2 diabetes had
greater impairments in mobility and more difficulties
performing basic activities of daily living (ADL) than
similarly aged non-diabetic persons (15). This leads to
loss of independence, and it may predict future hospita-
lization, institutionalization, and death (16).
Many studies have evaluated MSK manifestations in
diabetic patients, but most assessed only an individual
component, especially MSK involvement of the hands
and shoulders (24). Only few studies evaluated the whole
MSK system, including the limbs and back. Amongst
these was a pilot study on 208 patients with type 2
diabetes in which MSK complications, excluding osteoar-
thritis, were detected in 38% of the cases (3). A higher
prevalence (58%) was reported by other authors in a
cohort of 80 patients with type 2 diabetes (17). The lower
prevalence of MSK manifestations in our cohort could be
related to the fact that we excluded osteoarthritis, which
was a common finding in our study population.
The most frequent MSK complication in this study
was CTS, observed in (6.7%) of our patients. In the
literature, CTS is observed in up to 20% of patients
with diabetes (18). Similar to CTS, adhesive capsulitis
was observed in 6.7% of our patients; however, this
was less than the 25% reported from a British cohort.
(19) Adhesive capsulitis is a chronic disabling condition
associated with pain, requiring long-term treatment in
the form of physiotherapy and repeated injections. Un-
fortunately, the treatment is more prolonged in diabetic
patients, and surgical intervention may be required if the
condition is not treated early (20).
There is strong evidence that the development of
one complication predisposes to the development of
another. We found a significant association between
shoulder adhesive capsulitis and other MSK complica-
tions of diabetes, notably CTS, flexor tenosynovitis, and
limited joint mobility. Similarly, a Japanese group exam-
ined 302 diabetic patients in a case-control study and
Table 3. Determination of the most significant predictors of








Vascular complications 1.27 0.001* 3.57 (1.319.78)
Retinopathy 1.17 0.001* 3.21 (1.477.02)
*Significant association, PB0.05.

















Carpal tunnel syndrome (n17) 2 (12) 9 (53) 8 (47)*a 6 (35)a 12 (71)*b 9 (53)*b
Shoulder capsulitis (n17) 3 (18)a 8 (47)a 10 (59)*a 8 (47)a 11 (65)b 10 (59)*b
Diabetic amyotrophy (n12) 2 (16) 6 (50) 3 (25) 2 (17) 7 (58) 3 (25)
Flexor tenosynovitis (n11) 0 5 (45)b 6 (54)*a 2 (18)a 10 (91)*b 3 (27)a
Diabetic cheiroarthropathy (n8) 4 (50) 2 (25) 5 (63)* 3 (38) 4 (50) 7 (88)*
Crystal arthropathy (n7) 1 (14) 3 (43) 1 (14) 3 (43) 4 (57) 2 (29)
Diabetic sclerodactyly (n5) 2 (40)a 2 (40)a 5 (100)* 2 (40) 3 (60) 4 (80)*
Plantar fasciitis (n3) 0 3 (100) 1 (33) 1 (33) 3 (100) 1 (33)
Nephro, nephrology; Neuro, neurology; Retino, retinopathy; CAD, coronary artery disease.
Data are presented as frequency (percentages) unless otherwise stated. Multiple features were present.
Calculated by aFisher’s exact test and bChi-square test.
*Significant association, PB0.05.
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demonstrated a significant association between different
types of complications, especially flexor tenosynovitis and
limited joint mobility (20).
Over the past years, it has been shown that these strong
predictors predisposed to the development of MSK
complications in diabetic patients, (3, 19, 2125) of which
the most important is blood glucose control. In our study,
there was no association between blood glucose control
and MSK manifestations although we calculated the
mean HbA1c level from results obtained during the last
three visits, as a single HbA1c level does not correlate
with tissue levels of advanced glycosylation end products
(23). This is in line with the findings of Thomas et al. (24)
but contradicts the results obtained in a British cohort
that demonstrated a strong association between MSK
manifestations and poor blood glucose control (19).
Vascular complications are another important predis-
posing factor. We found a significant association between
MSK manifestations and vascular complications. Ardic
et al. (3) demonstrated that hand and shoulder syndrome
was most likely associated with retinopathy but not
nephropathy or neuropathy, in line with to our findings.
Although we detected a mathematical correlation be-
tween MSK complications and vascular complications,
retinopathy was the most significant predictor, with
patients having at least an 85% chance of developing
MSK complications.
Occupations that involved manual labor increased the
risk of hand complications in our patients. This finding is
in line with those reported by other authors (22, 25).
The risk of flexor tenosynovitis and CTS was higher in
our patients with peripheral neuropathy. This could be
attributed to the loss of sensation in addition to the
fact that the patients presented late when surgery was
mandatory.
At present, there are established guidelines for the
follow up of type 2 diabetic patients, which are aimed at
detecting microvascular complications, such as retino-
pathy, neuropathy, and nephropathy (26). However, none
has been established to guide clinicians to follow up
these patients for the detection of MSK complications.
Clinicians should therefore be aware of the possible
MSK complications of diabetes to intervene and provide
the best care for patients presenting with rheumatologic
disorders. Asking patients about their symptoms and
monitoring for signs of MSK complications can be an
important component of diabetes care.
Conclusion
Although not commonly recognized as a complication
of diabetes, MSK manifestations are present in about
18% of diabetic patients. With this frequency, we suggest
including examination of the periarticular region of
the joints in the hands and shoulders whenever a dia-
betic patient complains of joint pain as many of these
complications are potentially treatable, especially if
diagnosed early.
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